AnodyneWiki

Amoxapine

Amoxapine
Amoxapine
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass313.80 g/mol [1]
Melting point175-176 [1]
Solubility1.71e-01 g/L [1]
Predicted LogP2.6 [1]
Structural Identifiers
[]
Molecular formulaC17H16ClN3O
IUPAC name8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine
SMILESC1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
InChIInChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2
InChIKeyQWGDMFLQWFTERH-UHFFFAOYSA-N
CAS number14028-44-5
UNIIR63VQ857OT
PubChem CID2170
Pharmacokinetics[]
Elimination half-life8–10 hours (30 hours for chief active metabolite)
MetabolismHepatic (cytochrome P450 system)
ExcretionRenal (60%), feces (18%)[3]
Routes of administrationOral

Amoxapine (also known as Asendin, Demolox, Amoxan, Desmethylloxapin, Amoxapina, Asendis, Amoxapinum, Cl 67772, Defanyl or Cl-67772) is a substance of the 1-benzylpiperazine class.

Chemistry

 []

Amoxapine is achiral.

Amoxapine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Amoxapine acts by decreasing the reuptake of norepinephrine and serotonin (5-HT). [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction93 (5 contraindicated)
shared target25
shared target11

Medical side effects []

97 side effects listed on drug labels in (amoxapine).

  • Somnolence
  • Dry mouth
  • Constipation
  • Vision blurred
  • Lymphadenitis
  • Alopecia
  • Decreased appetite
  • Atrial fibrillation
  • Delusion
  • Eosinophilia
  • Gynaecomastia
  • Hallucination
  • Atrioventricular block
  • Hepatitis
  • Jaundice
  • Myocardial infarction
  • Acute coronary syndrome
  • Pancreatitis
  • Ileus paralytic
  • Petechiae
  • Purpura
  • Vascular purpura
  • Stomatitis
  • Cerebrovascular accident
  • Thrombocytopenia
  • Pollakiuria
  • Arrhythmia supraventricular
  • Tongue discolouration
  • Parotid gland enlargement
  • Testicular swelling
  • Abdominal pain
  • Gastrointestinal pain
  • Agranulocytosis
  • Asthenia
  • Fatigue
  • Ataxia
  • Confusional state
  • Feeling abnormal
  • Libido decreased
  • Disturbance in sexual arousal
  • Diarrhoea
  • Dizziness
  • Syncope
  • Oedema
  • Dermatitis
  • Rash
  • Body temperature increased
  • Drug fever
  • Flatulence
  • Headache
  • Hypertension
  • Hypotension
  • Inappropriate antidiuretic hormone secretion
  • Leukopenia
  • Mydriasis
  • Nasal congestion
  • Nausea
  • Nervousness
  • Tension
  • Neuroleptic malignant syndrome
  • Nightmare
  • Hypoaesthesia
  • Sensory loss
  • Palpitations
  • Pruritus
  • Convulsion
  • Shock
  • Loss of consciousness
  • Tachycardia
  • Tinnitus
  • Tremor
  • Urticaria
  • Vasculitis
  • Vomiting
  • Weight increased
  • Urinary retention
  • Accommodation disorder
  • Menstruation irregular
  • Dyspepsia
  • Disorientation
  • Agitation
  • Extrapyramidal disorder
  • Disturbance in attention
  • Mental disability
  • Dysgeusia
  • Galactorrhoea
  • Paraesthesia
  • Tingling sensation
  • Hypomania
  • Erectile dysfunction
  • Painful ejaculation
  • Lacrimation increased
  • Increased appetite
  • Coordination abnormal
  • Tardive dyskinesia
  • Insomnia
  • Breast enlargement

Indications

  • Agitation
  • Anxiety
  • Depression
  • Depressive disorder
  • Depressive symptom
  • Psychotic disorder

 []

  • Australia: Amoxapine is a Schedule 4.
  • Brazil: Amoxapine is a C1.[4]
  • United States: Amoxapine is Prescription only.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 2170, Amoxapine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2170
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Amoxapine. UNII: R63VQ857OT. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/R63VQ857OT
  3. Asendin, (amoxapine) dosing, indications, interactions, adverse effects, and more. Medscape Reference. http://reference.medscape.com/drug/amoxapine-342937#showall
  4. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 10:56:09
drugspromissing (no DrugsPRO reagent data)2026-11-20 10:56:05
erowidmissing (no Erowid substance of that name)2026-11-20 10:56:05
gsrsok2026-11-20 10:56:06
hmdbmissing (hmdb.ca refused automated access to HMDB0014683)2026-11-20 10:56:05
keggok2026-11-20 10:56:07
pubchemok2026-11-20 10:56:05
redditmissing (no r/tripreports posts mention it)2026-11-20 10:56:05
siderok2026-11-20 10:56:05
structureok2026-11-20 10:56:05
wikipediaok2026-11-20 10:56:05